MAPK3 and tuberculosis: The present study examines modulations in TCR-mediated intracellular calcium levels, activation of ZAP-70, PKC-theta, and MAPK signaling focusing on potential changes in ERK1/2 and p38 activation in the blood of TB pleurisy patients in a longitudinal study where patients have been followed up after 6 months of treatment.